$315 Million is the total value of Sio Capital Management, LLC's 49 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 74.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $15,896,000 | +37.5% | 683,425 | -0.8% | 5.05% | +16.3% |
| CI | Sell | CIGNA CORP | $14,598,000 | +4.5% | 52,611 | -0.8% | 4.64% | -11.6% |
| INGN | Sell | INOGEN INC | $12,657,000 | -0.4% | 521,295 | -0.8% | 4.02% | -15.7% |
| CNC | Sell | CENTENE CORP DEL | $9,883,000 | -9.5% | 127,011 | -1.6% | 3.14% | -23.4% |
| NARI | Sell | INARI MEDICAL INC | $4,174,000 | -45.4% | 57,466 | -48.9% | 1.33% | -53.8% |
| BHC | Sell | BAUSCH HEALTH COMPANIES INCput | $1,937,000 | -77.8% | 281,200 | -73.0% | 0.62% | -81.2% |
| NBSE | Sell | NEUBASE THERAPEUTICS INC | $102,000 | -89.3% | 259,441 | -71.4% | 0.03% | -91.1% |
| BHC | Exit | BAUSCH HEALTH COMPANIES INC | $0 | – | -6,700 | -100.0% | -0.02% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -692,357 | -100.0% | -0.15% | – |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -454,355 | -100.0% | -0.18% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -16,368 | -100.0% | -0.19% | – |
| Exit | ISOPLEXIS CORP | $0 | – | -407,102 | -100.0% | -0.33% | – | |
| Exit | PARDES BIOSCIENCES INC | $0 | – | -315,564 | -100.0% | -0.36% | – | |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -58,556 | -100.0% | -0.44% | – |
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -1,008,993 | -100.0% | -0.61% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -999,829 | -100.0% | -1.08% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -40,000 | -100.0% | -1.20% | – |
| HSKA | Exit | HESKA CORP | $0 | – | -39,566 | -100.0% | -1.40% | – |
| INBX | Exit | INHIBRX INC | $0 | – | -365,210 | -100.0% | -1.56% | – |
| BHVN | Exit | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD | $0 | – | -35,000 | -100.0% | -1.92% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -105,000 | -100.0% | -2.07% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -119,061 | -100.0% | -2.34% | – |
| NTUS | Exit | NATUS MEDICAL INC | $0 | – | -190,956 | -100.0% | -2.35% | – |
| Exit | SIGHT SCIENCES INC | $0 | – | -724,944 | -100.0% | -2.45% | – | |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -80,000 | -100.0% | -2.70% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -35,900 | -100.0% | -2.75% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -61,953 | -100.0% | -3.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.